🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Christopher J. Harvey

University of Kansas Medical Center

ORCID: 0000-0001-6103-1909
MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Supplementary Data from First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response

Figshare(2023)10.1158/1078-0432.22487576.v1
Top 100%
0DataRank
Top 100%0 citations

Justin F. Gainor, Margaret K. Callahan, Gerald S. Falchook, Russell K. Pachynski, Patricia LoRusso +29 more

Papers

Driven by 7 papers — median percentile 0. Top paper: “First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response”.

First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-4256
N/A
0DataRank · unranked
98 citations

Justin F. Gainor, Margaret K. Callahan, Gerald S. Falchook, Russell K. Pachynski, Patricia LoRusso +29 more

ICOS is upregulated on T cells following radiation and agonism combined with radiation results in enhanced tumor control

Scientific Reports(2022)10.1038/s41598-022-19256-8
N/A
0DataRank · unranked
21 citations

Jason R. Baird, Shelly Bambina, Gwen Kramer, Monica Gostissa, Christopher J. Harvey +3 more

Bivalent intra-spike binding provides durability against emergent Omicron lineages: Results from a global consortium

Cell Reports(2023)10.1016/j.celrep.2023.112014
N/A
0DataRank · unranked
41 citations

Kathryn M. Hastie, Sharon L. Schendel, Haoyang Li, Xiaoying Yu, Jeremy Shek +57 more

Supplementary Data from First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response

Figshare(2023)10.1158/1078-0432.22487576.v1
Top 100%
0DataRank
Top 100%0 citations

Justin F. Gainor, Margaret K. Callahan, Gerald S. Falchook, Russell K. Pachynski, Patricia LoRusso +29 more

Data from The Tumor Microenvironment Shapes Lineage, Transcriptional, and Functional Diversity of Infiltrating Myeloid Cells

(2023)10.1158/2326-6066.c.6548549.v1
N/A
0DataRank · unranked
0 citations

Viviana Cremasco, Hua Shen, Christopher J. Harvey, Kai W. Wucherpfennig, Daniel R. Goldstein +3 more

Predictors of left atrial appendage emptying velocity: Derivation and validation of CHIRP3(M-1) score

Heart Rhythm(2024)10.1016/j.hrthm.2024.09.065
N/A
0DataRank · unranked
5 citations

Ross Smith, Matthew Bajaj, Sarah Baghdadi, Riya Parikh, Robert Enders +14 more

QRS 3D voltage-time integral in narrow QRS complex – Establishing the normal reference range

Journal of Electrocardiology(2025)10.1016/j.jelectrocard.2025.154069
N/A
0DataRank · unranked
0 citations

Christopher J. Harvey, Uzair Mahmood, Jacob Baer, Nikhil Parimi, Ashutosh Bapat +6 more